Avidity Partners Management as of Dec. 31, 2020
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 95 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avantor (AVTR) | 6.0 | $185M | 6.6M | 28.15 | |
| Arvinas Ord (ARVN) | 4.9 | $152M | 1.8M | 84.93 | |
| Abbvie (ABBV) | 4.7 | $145M | 1.4M | 107.15 | |
| Eli Lilly & Co. (LLY) | 4.4 | $137M | 811k | 168.84 | |
| Astrazeneca Sponsored Adr (AZN) | 3.7 | $115M | 2.3M | 49.99 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 3.1 | $97M | 3.4M | 28.05 | |
| Quest Diagnostics Incorporated (DGX) | 3.1 | $94M | 792k | 119.17 | |
| BioMarin Pharmaceutical (BMRN) | 2.8 | $87M | 993k | 87.69 | |
| Biohaven Pharmaceutical Holding | 2.8 | $87M | 1.0M | 85.71 | |
| Horizon Therapeutics Pub L SHS | 2.8 | $86M | 1.2M | 73.15 | |
| Mirati Therapeutics | 2.7 | $84M | 380k | 219.64 | |
| I Mab Sponsored Ads (IMAB) | 2.4 | $75M | 1.6M | 47.15 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $74M | 3.3M | 22.24 | |
| Biogen Idec Inc option Call Option | 2.0 | $61M | 248k | 244.86 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.9 | $59M | 1.1M | 51.94 | |
| Change Healthcare | 1.9 | $58M | 3.1M | 18.65 | |
| Shattuck Labs (STTK) | 1.6 | $49M | 939k | 52.41 | |
| Natera (NTRA) | 1.6 | $48M | 480k | 99.52 | |
| Arena Pharmaceuticals Com New | 1.5 | $48M | 621k | 76.83 | |
| Chemocentryx | 1.5 | $47M | 757k | 61.92 | |
| Trillium Therapeutics Com New | 1.5 | $47M | 3.2M | 14.71 | |
| Apellis Pharmaceuticals (APLS) | 1.4 | $44M | 774k | 57.20 | |
| Cardinal Health (CAH) | 1.4 | $43M | 808k | 53.56 | |
| Organogenesis Hldgs (ORGO) | 1.3 | $42M | 5.5M | 7.53 | |
| Bausch Health Companies (BHC) | 1.3 | $41M | 2.0M | 20.80 | |
| Kadmon Hldgs | 1.3 | $40M | 9.6M | 4.15 | |
| Acceleron Pharma | 1.2 | $38M | 299k | 127.94 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $37M | 217k | 170.49 | |
| Athira Pharma (ATHA) | 1.2 | $36M | 1.0M | 34.25 | |
| Medtronic SHS (MDT) | 1.1 | $35M | 301k | 117.14 | |
| Catalent | 1.1 | $35M | 337k | 104.07 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $35M | 147k | 236.34 | |
| Anika Therapeutics (ANIK) | 1.1 | $33M | 731k | 45.26 | |
| Sigilon Therapeutics | 1.1 | $33M | 688k | 48.03 | |
| EXACT Sciences Corporation (EXAS) | 1.1 | $33M | 247k | 132.49 | |
| Essa Pharma Com New (EPIX) | 1.0 | $31M | 2.6M | 11.93 | |
| Cardiff Oncology (CRDF) | 0.9 | $29M | 1.6M | 17.99 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $29M | 300k | 95.85 | |
| ACADIA Pharmaceuticals (ACAD) | 0.9 | $28M | 528k | 53.46 | |
| Aurinia Pharmaceuticals (AUPH) | 0.9 | $28M | 2.0M | 13.83 | |
| Zymeworks | 0.9 | $27M | 578k | 47.26 | |
| Blueprint Medicines (BPMC) | 0.9 | $27M | 240k | 112.15 | |
| Alphatec Hldgs Com New (ATEC) | 0.9 | $27M | 1.9M | 14.52 | |
| Bioxcel Therapeutics (BTAI) | 0.8 | $25M | 547k | 46.20 | |
| AtriCure (ATRC) | 0.8 | $25M | 447k | 55.67 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.8 | $25M | 1.2M | 20.03 | |
| Sotera Health (SHC) | 0.6 | $19M | 700k | 27.44 | |
| Curis Com New | 0.6 | $19M | 2.3M | 8.19 | |
| Si-bone (SIBN) | 0.6 | $19M | 640k | 29.90 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.6 | $18M | 4.0M | 4.45 | |
| Bellus Health Com New | 0.6 | $18M | 5.7M | 3.06 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.6 | $17M | 965k | 17.67 | |
| Intellia Therapeutics (NTLA) | 0.5 | $17M | 303k | 54.40 | |
| Alpine Immune Sciences | 0.5 | $16M | 1.2M | 12.60 | |
| Reata Pharmaceuticals Cl A | 0.5 | $16M | 126k | 123.62 | |
| Surgery Partners (SGRY) | 0.5 | $15M | 531k | 29.01 | |
| Certara Ord (CERT) | 0.4 | $14M | 405k | 33.72 | |
| Sutro Biopharma (STRO) | 0.4 | $14M | 626k | 21.71 | |
| Codexis (CDXS) | 0.4 | $13M | 600k | 21.83 | |
| Harpoon Therapeutics | 0.4 | $13M | 785k | 16.61 | |
| Olema Pharmaceuticals (OLMA) | 0.4 | $13M | 270k | 48.08 | |
| Oncosec Medical Incorporated | 0.4 | $13M | 2.0M | 6.45 | |
| Kura Oncology (KURA) | 0.4 | $11M | 348k | 32.66 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $10M | 392k | 26.54 | |
| Castle Biosciences (CSTL) | 0.3 | $10M | 150k | 67.15 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $9.8M | 1.4M | 6.86 | |
| Scynexis Com New (SCYX) | 0.3 | $9.6M | 1.3M | 7.65 | |
| Oak Street Health | 0.3 | $9.2M | 150k | 61.16 | |
| Gritstone Oncology Ord (GRTSQ) | 0.3 | $8.4M | 2.1M | 3.94 | |
| Vesper Healthcare Acqstn Cor Unit 99/99/9999 | 0.2 | $7.3M | 600k | 12.12 | |
| Igm Biosciences (IGMS) | 0.2 | $7.1M | 80k | 88.29 | |
| Ligand Pharmaceuticals Com New (LGND) | 0.2 | $6.2M | 62k | 99.45 | |
| Cogent Biosciences (COGT) | 0.2 | $5.8M | 520k | 11.23 | |
| Outset Med (OM) | 0.2 | $5.7M | 100k | 56.84 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $5.6M | 500k | 11.14 | |
| Arya Sciences Acquisition Com Cl A | 0.2 | $5.4M | 500k | 10.85 | |
| Ocular Therapeutix (OCUL) | 0.2 | $5.2M | 250k | 20.70 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.2 | $5.1M | 400k | 12.81 | |
| Five Prime Therapeutics | 0.2 | $5.1M | 300k | 17.01 | |
| Phathom Pharmaceuticals (PHAT) | 0.2 | $5.1M | 153k | 33.22 | |
| Albireo Pharma | 0.2 | $4.7M | 125k | 37.51 | |
| Helix Acquisition Corp Com Cl A | 0.1 | $4.5M | 400k | 11.37 | |
| Lifesci Acquisition Ii Corp | 0.1 | $4.3M | 400k | 10.67 | |
| Panacea Acquisition Corp Unit 99/99/9999 | 0.1 | $3.8M | 300k | 12.76 | |
| Bctg Acquisition Corp | 0.1 | $3.4M | 300k | 11.44 | |
| Iteos Therapeutics (ITOS) | 0.1 | $3.1M | 93k | 33.82 | |
| Keros Therapeutics (KROS) | 0.1 | $2.8M | 40k | 70.55 | |
| Rocket Pharmaceuticals (RCKT) | 0.1 | $2.7M | 50k | 54.84 | |
| Annexon (ANNX) | 0.1 | $1.8M | 70k | 25.03 | |
| Accolade (ACCD) | 0.1 | $1.7M | 40k | 43.50 | |
| Bioatla (BCAB) | 0.1 | $1.7M | 50k | 34.02 | |
| Nurix Therapeutics (NRIX) | 0.1 | $1.6M | 50k | 32.88 | |
| American Well Corp Cl A | 0.0 | $1.3M | 50k | 25.34 | |
| Relay Therapeutics (RLAY) | 0.0 | $1.2M | 30k | 41.57 | |
| Inozyme Pharma (INZY) | 0.0 | $200k | 9.7k | 20.65 |
